CoChat

Effects of probiotics on type II diabetes mellitus: a meta-analysis

Open access
Tao, Yun-Wen, Gu, Ying-Luo, Mao, Xin-Qi, Zhang, Lei, Pei, Yu-Fang · 2020 · Journal of Translational Medicine

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Objective: The purpose of the present study was to evaluate the effectiveness of probiotics on type II diabetes mellitus (T2DM). Methods: We performed a comprehensive search on PubMed, Web of Science, China National Knowledge Infrastructure, Chinese Scientific Journal Databases, Wan Fang database and China biology medicine disc for relevant studies published before June 2019. Glycated hemoglobin A1c (HbA1c), homeostasis model assessment of insulin resistance (HOMA-IR) and fasting blood glucose (FBG) were used as indicators for T2DM. Inverse-variance weighted mean difference (WMD) with 95% confidence interval (CI) was calculated for the mean HbA1c, FBG and HOMA-IR changes from baseline. Results: 15 randomized controlled trials (RCT) with a total of 902 participants were included into the meta-analysis. Considering the clinical heterogeneity caused by variation of dosage and duration of probiotic treatment, random-effects model was used to estimate the pooled WMD. Significantly greater reduction in HbA1c% (WMD = − 0.24, 95% CI [− 0.44, − 0.04], p = 0.02), FBG (WMD = − 0.44 mmol/L, 95% CI [− 0.74, − 0.15], p = 0.003) and HOMA-IR (WMD = − 1.07, 95% CI [− 1.58, − 0.56], p < 0.00001) were observed in probiotics treated group. Further sensitivity analysis verified the reliability and stability of our results. Conclusion: The results of our meta-analysis indicated that probiotics treatment may reduce HbA1c, FBG and insulin resistance level in T2DM patients. More clinical data and research into the mechanism of probiotics are needed to clarify the role of probiotics in T2DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-020-02213-2

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart of literature inclusion
Fig. 1 Flow chart of literature inclusionCC BY · PubMed Central
Fig. 2 Risk of bias assessment for included studies. a Risk of Bias Graph. Literature quality was evaluated according to the following six points: ①generation of random distribution schemes; ②covert grouping; ③implementation of the blind method; ④Integrity of the data; ⑤non-selective reporting of results; ⑥other sources of bias. There are three bias assessment criteria “Low”, “High” and “Unclear” for each point, shown as the color green, yellow and red, respectively. b Risk of bias summary. The quality assessment of each literature has been shown. The color green, yellow and red represent low, high and unclear risk of bias, respectively
Fig. 2 Risk of bias assessment for included studies. a Risk of Bias Graph. Literature quality was evaluated according to the following six points: ①generation of random distribution schemes; ②covert grouping; ③implementation of the blind method; ④Integrity of the data; ⑤non-selective reporting of results; ⑥other sources of bias. There are three bias assessment criteria “Low”, “High” and “Unclear” for each point, shown as the color green, yellow and red, respectively. b Risk of bias summary. The quality assessment of each literature has been shown. The color green, yellow and red represent low, high and unclear risk of bias, respectivelyCC BY · PubMed Central
Fig. 3 The effect of probiotics on HbA1c (%) in T2DM patients. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect size
Fig. 3 The effect of probiotics on HbA1c (%) in T2DM patients. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect sizeCC BY · PubMed Central
Fig. 4 Sensitivity analysis of the effects of probiotics on HbA1c (%) in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIs
Fig. 4 Sensitivity analysis of the effects of probiotics on HbA1c (%) in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIsCC BY · PubMed Central
Fig. 5 The effect of probiotics on FBG (mmol/L) in T2DM patitents. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect size
Fig. 5 The effect of probiotics on FBG (mmol/L) in T2DM patitents. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect sizeCC BY · PubMed Central
Fig. 6 Sensitivity analysis of the effects of probiotics on FBG (mmol/L) in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIs
Fig. 6 Sensitivity analysis of the effects of probiotics on FBG (mmol/L) in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIsCC BY · PubMed Central
Fig. 7 The effect of probiotics on HOMA-IR in T2DM patients. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect size
Fig. 7 The effect of probiotics on HOMA-IR in T2DM patients. Mean differences of change from baseline and 95% confidence intervals (CIs) are shown. Pooled estimates were calculated by the inverse-variance weighted random-effects meta-analysis. The squares indicate the effect of probiotics in a particular trial and the horizontal lines represent the corresponding 95% CIs. The diamond indicated the pooled effect sizeCC BY · PubMed Central
Fig. 8 Sensitivity analysis of the effects of probiotics on HOMA-IR in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIs
Fig. 8 Sensitivity analysis of the effects of probiotics on HOMA-IR in T2DM patients. Results were computed by omitting each trial in turn. Random-effects meta-analysis were used to estimate the pooled effect size. The two ends of the dotted lines represent the 95% CIsCC BY · PubMed Central
Fig. 9 Egger’s regression asymmetry test for effects of probiotics on HbA1c% in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication bias
Fig. 9 Egger’s regression asymmetry test for effects of probiotics on HbA1c% in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication biasCC BY · PubMed Central
Fig. 10 Egger’s regression asymmetry test for effects of probiotics on FBG in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication bias
Fig. 10 Egger’s regression asymmetry test for effects of probiotics on FBG in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication biasCC BY · PubMed Central
Fig. 11 Egger’s regression asymmetry test for effects of probiotics on HOMA-IR in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication bias
Fig. 11 Egger’s regression asymmetry test for effects of probiotics on HOMA-IR in T2DM patients. Individual studies are represented by blue dot. Success of the CI for the intercept to include zero indicates symmetry in the funnel plot and give evidence of no publication biasCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Yang H, Guo H, Hao HW, Zeng Q, Guo FF, Wang N, Wang BH, Ma YX. Effect on blood glucose of yogurt supplemented with probiotics N1115 in type 2 diabetes mellitus. Food Sci Technol. 2018;43:14–9.
  2. Mobini R, Tremaroli V, Ståhlman M, Karlsson F, PhD MLM, Ljungberg M, Sohlin M, Forslund HB, Perkins R, Bäckhed F. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab. 2016;19:579. · DOI · Paper page

Cited by

See all 194

Metadata

Authors
Tao, Y.-W., Gu, Y.-L., Mao, X.-Q., Zhang, L., & Pei, Y.-F.
Affiliations
Soochow University (CN)
Corresponding author
  • Zhang, Lei
  • Pei, Yu-Fang
Venue
Journal of Translational Medicine
Published
2020-01-17
Volume
18
Issue
1
Pages
30-30
ISSN
1479-5876 (ISSN-L)
OpenAlex
W3007815550
Cited by
173
References
30
Citations by year
2026: 16 · 2025: 30 · 2024: 32 · 2023: 34 · 2022: 26 · 2021: 24 · 2020: 11
FWCI
2.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (31771417, 31571291)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, type 2 diabetes, HbA1c, insulin resistance, fasting blood glucose, glycemic control, gut microbiota
MeSH terms
Blood Glucose, China, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Randomized Controlled Trials as Topic, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of probiotics on type II diabetes mellitus: a meta-analysis. https://app.cochat.ai/papers/10.1186/s12967-020-02213-2
The paper
Tao, Y.-W., Gu, Y.-L., Mao, X.-Q., Zhang, L., & Pei, Y.-F. (2020). Effects of probiotics on type II diabetes mellitus: a meta-analysis. Journal of Translational Medicine. https://doi.org/10.1186/s12967-020-02213-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.